Literature DB >> 28756606

A novel imaging technique for better detecting new lesions in multiple sclerosis.

Paul Eichinger1, Hanni Wiestler2, Haike Zhang3, Viola Biberacher4,5, Jan S Kirschke3, Claus Zimmer3, Mark Mühlau4,5, Benedikt Wiestler3.   

Abstract

We developed a tool that performs longitudinal subtraction of 3D double inversion recovery (DIR) images in follow-up magnetic resonance (MR) examinations of patients with multiple sclerosis. As DIR sequences show a high lesion-to-parenchyma contrast, we hypothesized that such a tool might lead to increased sensitivity for new lesions as well as to speeding up the routine clinical work-up of follow-up MR imaging in multiple sclerosis by directly visualizing new lesions. DIR subtraction images of serial MR examinations were calculated in 106 patients with multiple sclerosis. Existence of new lesions was assessed in three different ways: by standard visual comparison, by FLAIR, and by DIR subtraction maps. A reference standard, to which the single modalities were compared, was defined by combining all information from all readouts and all readers. The presence and number of new lesions were determined and the time needed for analysis measured. Accuracy of detecting overall existence of new lesions using DIR subtraction maps was significantly higher than using visual comparison (96 vs. 86%, p = 0.013) or FLAIR subtraction maps (p < 0.001), with increased sensitivity and higher negative predictive value. Significantly more new lesions were detected when using DIR subtraction maps (p < 0.001). Analyzing subtraction maps took less than a third of the time needed for the standard visual comparison (p = 0.007). Thus, DIR subtraction maps improve the detection of new lesions in a clinical setting both in terms of accuracy and in terms of speed.

Entities:  

Keywords:  Double inversion recovery; Longitudinal subtraction imaging; Magnetic resonance imaging; Multiple sclerosis

Mesh:

Year:  2017        PMID: 28756606     DOI: 10.1007/s00415-017-8576-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  28 in total

1.  Comparison of 3D double inversion recovery and 2D STIR FLAIR MR sequences for the imaging of optic neuritis: pilot study.

Authors:  Jérôme Hodel; Olivier Outteryck; Anne-Laure Bocher; Hélène Zéphir; Oriane Lambert; Mohamed Amine Benadjaoud; David Chechin; Jean-Pierre Pruvo; Patrick Vermersch; Xavier Leclerc
Journal:  Eur Radiol       Date:  2014-08-23       Impact factor: 5.315

2.  N4ITK: improved N3 bias correction.

Authors:  Nicholas J Tustison; Brian B Avants; Philip A Cook; Yuanjie Zheng; Alexander Egan; Paul A Yushkevich; James C Gee
Journal:  IEEE Trans Med Imaging       Date:  2010-04-08       Impact factor: 10.048

3.  Automatic lesion incidence estimation and detection in multiple sclerosis using multisequence longitudinal MRI.

Authors:  E M Sweeney; R T Shinohara; C D Shea; D S Reich; C M Crainiceanu
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-05       Impact factor: 3.825

4.  Length of optic nerve double inversion recovery hypersignal is associated with retinal axonal loss.

Authors:  N Hadhoum; J Hodel; S Defoort-Dhellemmes; A Duhamel; E Drumez; H Zéphir; J P Pruvo; X Leclerc; P Vermersch; O Outteryck
Journal:  Mult Scler       Date:  2015-07-30       Impact factor: 6.312

5.  Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis.

Authors:  Massimiliano Calabrese; Nicola De Stefano; Matteo Atzori; Valentina Bernardi; Irene Mattisi; Luigi Barachino; Aldo Morra; Luciano Rinaldi; Chiara Romualdi; Paola Perini; Leontino Battistin; Paolo Gallo
Journal:  Arch Neurol       Date:  2007-10

6.  Multi-contrast, isotropic, single-slab 3D MR imaging in multiple sclerosis.

Authors:  Bastiaan Moraal; Stefan D Roosendaal; Petra J W Pouwels; Hugo Vrenken; Ronald A van Schijndel; Dominik S Meier; Charles R G Guttmann; Jeroen J G Geurts; Frederik Barkhof
Journal:  Eur Radiol       Date:  2008-05-29       Impact factor: 5.315

7.  Subtraction MR images in a multiple sclerosis multicenter clinical trial setting.

Authors:  Bastiaan Moraal; Dominik S Meier; Peter A Poppe; Jeroen J G Geurts; Hugo Vrenken; William M A Jonker; Dirk L Knol; Ronald A van Schijndel; Petra J W Pouwels; Christoph Pohl; Lars Bauer; Rupert Sandbrink; Charles R G Guttmann; Frederik Barkhof
Journal:  Radiology       Date:  2008-11-26       Impact factor: 11.105

8.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

9.  Lesion detection at seven Tesla in multiple sclerosis using magnetisation prepared 3D-FLAIR and 3D-DIR.

Authors:  Wolter L de Graaf; Jaco J M Zwanenburg; Fredy Visser; Mike P Wattjes; Petra J W Pouwels; Jeroen J G Geurts; Chris H Polman; Frederik Barkhof; Peter R Luijten; Jonas A Castelijns
Journal:  Eur Radiol       Date:  2011-08-27       Impact factor: 5.315

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  2 in total

1.  Automated segmentation of changes in FLAIR-hyperintense white matter lesions in multiple sclerosis on serial magnetic resonance imaging.

Authors:  Paul Schmidt; Viola Pongratz; Pascal Küster; Dominik Meier; Jens Wuerfel; Carsten Lukas; Barbara Bellenberg; Frauke Zipp; Sergiu Groppa; Philipp G Sämann; Frank Weber; Christian Gaser; Thomas Franke; Matthias Bussas; Jan Kirschke; Claus Zimmer; Bernhard Hemmer; Mark Mühlau
Journal:  Neuroimage Clin       Date:  2019-05-02       Impact factor: 4.881

2.  Differential Effects of Fingolimod and Natalizumab on Magnetic Resonance Imaging Measures in Relapsing-Remitting Multiple Sclerosis.

Authors:  S Grahl; M Bussas; B Wiestler; P Eichinger; C Gaser; J Kirschke; C Zimmer; A Berthele; B Hemmer; M Mühlau
Journal:  Neurotherapeutics       Date:  2021-09-24       Impact factor: 7.620

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.